Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression

Nutrition and Cancer

Volumn 63, Issue 5, 2011, Pages 795-801

  Dai, Yumin ^a   Hogan, Shelly ^b   Schmelz, Eva M ^a   Ju, Young H ^a   Canning, Corene ^c   Zhou, Kequan ^c  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; GRAVIOLA FRUIT EXTRACT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL LINE; CELL STRAIN MCF 10A; CELL STRAIN MDA MB 468; CELL VIABILITY; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG PURIFICATION; FEMALE; GENE EXPRESSION; GRAVIOLA FRUIT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; ANNONA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; FRUIT; G0 PHASE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; PLANT EXTRACTS; RANDOM ALLOCATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960617317     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.563027     Document Type: Article

References (26)

1. Bray F, McCarron P, and Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6, 229-239, 2004. (Pubitemid 39440251)
2. American Cancer Society: Breast Cancer Facts and Figures 2010-2011, Cancer.org: Atlanta, GA, 2010.
3. Rock CL and Demark-Wahnefried W: Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr 132, 3504S-3509, 2002.
4. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96, 1027-1039, 1996. (Pubitemid 27382158)
5. Duffy C and Cyr M: Phytoestrogens: potential benefits and implications for breast cancer survivors. J Womens Health (Larchmt) 12, 617-631, 2003. (Pubitemid 37266005)
6. Mukhtar H and Ahmad N: Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71, 1698-1702, 2000.
7. Adewole SO and Caxton-Martins EA: Morphological changes and hypoglycemic effects of Annona muricata linn. (annonaceae) leaf aqueous extract on pancreatic Β-cells of streptozotocin-treated diabetic rats. Afr J Biomed Res 9, 173-187, 2006.
8. Filmus J, Trent JM, Pollak MN, and Buick RN: Epidermal growth factor receptor gene-amplifiedMDA-468 breast cancer cell line and its nonamplified variants. Mol Cell Biol 7, 251-257, 1987. (Pubitemid 17230407)
9. Woodburn JR: The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82, 241-250, 1999. (Pubitemid 29255919)
10. Ciardiello F and Tortora G: Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti- EGFR drugs. Euro J Cancer 39, 1348-1354, 2003. (Pubitemid 36773776)
11. Salomon DS, Brandt R, Ciardiello F, and Normanno N: Epidermal growth factor-related peptides and their receptors in human malignancies. Cr Rev Oncol-Hem 19, 183-232, 1995.
12. Lichtner RB: Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies. Biomed Pharmacother 57, 447-451, 2003. (Pubitemid 37452413)
13. Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, et al.: Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res 7, 1850-1855, 2001. (Pubitemid 32994816)
14. Goss G, Hirte H, Miller WH, Lorimer IA, Stewart D, et al.: A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group. Inves New Drugs 23, 147-155, 2005. (Pubitemid 40386232)
15. Reeves PG: Components of the AIN-93 diets as improvements in the AIN- 76A diet. J Nutr 127, 838S-841S, 1997. (Pubitemid 27209452)
16. GottardisMM, Wagner RJ, Borden EC, and Jordan VC: Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro. Cancer Res 49, 4765-4769, 1989. (Pubitemid 19213621)
17. Sun J and Hai Liu R: Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett 241, 124-134, 2006.
18. Kleinridders A, PogodaHM, Irlenbusch S, Smyth N, KonczC, et al.: PLRG1 is an essential regulator of cell proliferation and apoptosis during vertebrate development and tissue homeostasis. Mol Cell Biol 29, 3173-3185, 2009.
19. Crowe DL and Chandraratna RA: A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res 6, R546-555, 2004.
20. Noble M, Barrett P, Endicott J, Johnson L, McDonnell J, et al.: Exploiting structural principles to design cyclin-dependent kinase inhibitors. Biochim Biophys Acta 1754, 58-64, 2005. (Pubitemid 41797687)
21. Athar M, Kim AL, Ahmad N, Mukhtar H, Gautier J, et al.: Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53. Biochem Biophys Res Commun 277, 107-111, 2000.
22. Chung H, Jung YM, Shin DH, Lee JY, Oh MY, et al.: Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts. Int J Cancer 122, 816-822, 2008.
23. Filmus J, Trent JM, Pollak MN, and Buick RN: Epidermal growth factor receptor gene-amplifiedMDA-468 breast cancer cell line and its nonamplified variants. Mol Cell Biol 7, 251-257, 1987. (Pubitemid 17230407)
24. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, et al.: ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117, 2051-2058, 2007. (Pubitemid 47224766)
25. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103, 211-225, 2000.
26. Yarden Y and Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2, 127-137, 2001. (Pubitemid 33674041)